Dante Julca Marín

Medical Graduate from @UNMSM_ 🇵🇪 | Interested in Internal Medicine 🩺 | Musician 🎸🪈

[Kelly Meza, MD @KellyMezaMD]

Thrilled to share our recently published article, “Advancing cancer research in resource-limited settings” in AACR Cancer Epidemiology, Biomarkers & Prevention @AACR @CEBP_AACR

In this work, we underscore the critical role of locally driven innovation, strategic collaborations, and community engagement in advancing impactful cancer research globally.

We are especially grateful to AACR leadership for their continued support in amplifying diverse and emerging voices in oncology research @AACR_CEO

[1-min ID consult @1min_IDconsult]

【Daptomycin: Important to know】

Let's remember 5 important key points of daptomycin!

Level: Basic to intermediate

#IDMedEd #IDFellow #IMResident #PharmD #Antimicrobials

[Dante Julca Marín @JulcaDante]

@anth_ramosMD @AAPPHealth Felicitaciones doctor!! 🥳

[Andrea Anampa-Guzmán (she/ella) @AndreaAnampaG]

Honored to moderate today’s @ICONplc & @ASCPT_ClinPharm on strategic approaches for Early Clinical Trials in Neurodegenerative Diseases. We covered trial objectives, population selection, patient engagement & biomarker strategy
https://t.co/EbUNUA2gM1

[Andrea Anampa-Guzmán (she/ella) @AndreaAnampaG]

I’m excited to share our study on inaccurate info about #ProstateCancer on social media. We found misinformation is widespread, multilingual & behavior-changing. Proud to have contributed with Dr. @LoebStacy and team
https://t.co/OUi8XrhijA

#pcsm #DigitalHealth #SoMe

[Dante Julca Marín @JulcaDante]

#MedTwitter @HemOncFellows @AAPPHealth @IMG_Oncologists @LatinxOncology

[Dante Julca Marín @JulcaDante]

Happy to share our new meta-analysis in JCP (BMJ Group, Q1)! 🔬

We compared 🧊 Frozen Section (FS) vs 🪶 Touch Imprint (TI) for sentinel lymph node biopsy in breast cancer after neoadjuvant therapy.

🎯 We found that FS showed higher sensitivity and specificity than TI 📊

[Dante Julca Marín @JulcaDante]

🔗 Links to the article:

➡️ BMJ / JCP: https://t.co/rasW0OkIzW

➡️ DOI: 10.1136/jcp-2023-208862

➡️ PubMed: https://t.co/u0NUZGF0Ce

[Andrea Anampa-Guzmán (she/ella) @AndreaAnampaG]

Our piece More Than Survival A Final-Year Med Student’s Fight for Access to Cancer Treatment in #Peru in @ASCO Connection. Dr. Jhoana Tapia-Hernandez's story shows that surviving cancer often means surviving bureaucracy, too

https://t.co/F8g91zzDim

#Survivorship #BCSM #SurvOnc

[Andrea Anampa-Guzmán (she/ella) @AndreaAnampaG]

Honored to be selected as a 2025–2026 @FDA - @AACR Oncology Educational Fellow! Excited to learn + contribute to oncology drug development and regulation over the next year

#AACR #FDA #Oncology #RegulatoryScience #DrugDevelopment #CancerCare #ClinicalPharmacology #HOFelllows

[Dante Julca Marín @JulcaDante]

In 2016–2020, mortality was 1.7 ♂️ and 1.2 ♀️ (0–14 yrs, per 100,000) in Peru & Ecuador.

Only Peru showed a significant increase ⬆️ → boys in Highlands (17%) and girls in Lima (13%)

[Dante Julca Marín @JulcaDante]

Happy to share our latest publication in ALL 📄: childhood mortality in Peru 🇵🇪 and Ecuador 🇪🇨
https://t.co/8lcPufn5P5

We evaluated mortality trends 📊 by country and sex from 2005–2020.

#MedTwitter @HemOncFellows @AAPPHealth @IMG_Oncologists @LatinxOncology

[Dante Julca Marín @JulcaDante]

This #ASCO25 was my first ASCO annual meeting, and I’m honored to have presented our poster at the Abstract Forum for Medical Students and Residents at @ASCOTECAG . In addition, another of our abstracts was accepted as an electronic abstract!

These accomplishments reflect the hard work of our Oncology Student Interest Group at my medical school, @MedicinaUNMSM @UNMSM_ . Our group is part of the @ASCO OSIG Program, and I had the privilege of serving as its President last year.

Grateful for the opportunity to attend, present, and connect with so many inspiring people. I’m sure I’ll be back! @HemOncFellows @AAPPHealth #MedTwitter
@IMG_Oncologists @LatinxOncology

[Dante Julca Marín @JulcaDante]

So glad I had the chance to connect with amazing people at #ASCO25!

[Pamela Contreras Chavez @PamChMD]

Always LOVE meeting peruvian trainees interested in Hemeonc! Also met with a colleague from Mexico! And so happy to have seen my dear friend @AndreaAnampaG !!! IMG power!
Diversity is key. 🇵🇪 🇲🇽 🇺🇸

[Dante Julca Marín @JulcaDante]

Presenting my poster at the Abstract Forum for Medical Students & Residents at the ASCO Annual Meeting — great experience!

#ASCO25 #MedTwitter

[Dante Julca Marín @JulcaDante]

Link to the article! 🔗

https://t.co/QWiBB8xABV

[Dante Julca Marín @JulcaDante]

Check out our latest article in Journal of Stroke and Cerebrovascular Diseases! 🧠 We analyze stroke mortality trends in Latin America & the Caribbean and project changes through 2035. 📊

#MedTwitter #MedX #stroke

[Dante Julca Marín @JulcaDante]

Our key findings:

📉 Stroke mortality ↓ in 15/18 LAC countries
⚠️ ↑ Male mortality: Venezuela, Cuba & Peru
⚡️ Largest declines: Chile, Puerto Rico & El Salvador
📊 Aging → More crude deaths despite lower risk

#MedTwitter #MedX #stroke

[Dante Julca Marín @JulcaDante]

@imghelpinghand [email protected]

[Dante Julca Marín @JulcaDante]

@anth_ramosMD @UNMSM_ @UR_Med @WilmotCancer gracias doctor! 🎉 San Fernando ⚕️🦾

[Dante Julca Marín @JulcaDante]

Hi #MedTwitter!

I’m Dante Julca, a 6th-year (6/7) Peruvian 🇵🇪 medical student at @UNMSM_

2 months ago, I had my first US clinical experience at @UR_Med and @WilmotCancer🦀 It wasn’t going to be easy as it was my first time leaving my country! (1/4)

#medstudent #MedX